Mutation detail:
| Mutation site | D614G |
| Virus | SARS-CoV-2 |
Mutation level  |
Amino acid level |
| Gene/protein/region type | S |
| Gene ID | 43740568 |
| Country | Belgium,France,China,Germany,Netherlands,Brazil,Canada,Italy,Australia,Japan,Japan,USA,Spain |
| Mutation type |
nonsynonymous mutation |
| Genotype/subtype/clade | 20H/20J |
| Sample |
Human |
| Variants | Beta/Gamma |
| Viral reference sequence | MN908947.3 |
| Drug/antibody/vaccine | - |
| Transmissibility |
- |
| Transmission mechanism | - |
| Pathogenicity |
- |
| Pathogenicity mechanism | - |
| Immune escape mutation | - |
| Immune escape mechanism | - |
| RT-PCR primers probes | - |
Protein detail:
| Protein name | Spike glycoprotein |
| Uniprot protein ID | P0DTC2 |
| Protein length | 1273 amino acids |
| Protein description | Spike protein is one of the structural proteins of SARS-CoV-2. The monomeric protein consists of one large ectodomain, a single-pass transmembrane anchor, and a short intracellular tail at C-terminus. It encompasses 22 glycosylation sites. S protein cleaves into two subunits namely S1 and S2 following receptor recognition. Receptor Binding Domain (RBD) in S1 subunit plays a major role in ACE2 receptor binding. |
Literature information:
| Pubmed ID | 32374903 |
| Clinical information | No |
| Disease | - |
| Published year | 2020 |
| Journal | INTERNATIONAL JOURNAL OF CLINICAL PRACTICE |
| Title | SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate |
| Author | Manuel Becerra-Flores,Timothy Cardozo |
| Evidence | The major mutation detected to date in the SARS-CoV-2 viral envelope spike protein, which is responsible for virus attachment to the host and is also the main target for host antibodies, is a mutation of an aspartate (D) at position 614 found frequently in Chinese strains to a glycine (G) |